Why some guys with certain genes get worse prostate cancer
Prostate cancer risk, screening and management in patients with germline BRCA1/2 mutations
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
Surprising Findings
BRCA2 carriers may have higher prostate cancer-specific mortality, but often die from other cancers first.
People assume catching prostate cancer early saves BRCA2 carriers—but the study suggests they’re more likely to die from breast, pancreatic, or other cancers before prostate cancer kills them.
Practical Takeaways
Men with known BRCA2 mutations should ask their doctor about a specialized screening protocol—like annual MRI + targeted biopsy—starting at age 40.
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
Surprising Findings
BRCA2 carriers may have higher prostate cancer-specific mortality, but often die from other cancers first.
People assume catching prostate cancer early saves BRCA2 carriers—but the study suggests they’re more likely to die from breast, pancreatic, or other cancers before prostate cancer kills them.
Practical Takeaways
Men with known BRCA2 mutations should ask their doctor about a specialized screening protocol—like annual MRI + targeted biopsy—starting at age 40.
Publication
Journal
Nature Reviews Urology
Year
2023
Authors
P. Rajwa, F. Quhal, B. Pradère, G. Gandaglia, G. Ploussard, M. Leapman, J. Gore, A. Paradysz, D. Tilki, A. Merseburger, T. Morgan, A. Briganti, G. Palapattu, S. Shariat
Related Content
Claims (6)
Men who inherit a faulty BRCA2 gene are 2 to 4 times more likely to get prostate cancer than men without it.
Having a BRCA1 mutation raises prostate cancer risk, but not as much as having a BRCA2 mutation.
Standard PSA tests or MRI scans aren’t good enough on their own to find dangerous prostate cancers in men with BRCA mutations—they need better ways to tell who’s really at risk.
We don’t yet know if screening men with BRCA mutations for prostate cancer actually saves lives or improves how they feel long-term.
Germline mutations in BRCA1 and BRCA2 genes confer a significantly elevated risk of developing prostate cancer in men, independent of family history of prostate cancer.